Comprehensive Industry Report Offers Forecast and Analysis on Octreotide Market 2016 - 2026

Octreotide are amino acid monomer which is attached to amide group. The octreotide acts similar to the hormone somatostatin. Octreotide basically lowers the variety of hormone such as insulin, glucagon, growth hormone and others, Octreotide reduces chemical messengers such as gastrin, vasoactive intestinal peptide that cause disease symptoms. Octreotide depending upon the severity generally severe diarrhea, acromegaly as well as for treating flushing in patients with tumors. Octreotride is also used to reduction of the side effects from cancer chemotherapy. The global Octreotide market was estimated to be around U.S $ 1.6 Bn. in 2013 .The estimated CAGR for Octreotide market from 2012 to 2013 was approximately 5%. The use of octreotide is expected to grow because of increase in number of people diagnosed with cancer, diarrhea and tumors.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1266

Octreotide Market: Drivers and Restraints

The global demand for octreotide is driven by growing number of people under the diagnosis of cancer. In 2012, there were estimated 14.1 million cases of cancer .It is estimated that by 2035, the number of people suffering from cancer will be around 24 million. These estimate shows that the demand for treatment drugs such as octreotide will grow. It is forecasted that around 2200 children die every day due to severe diarrhea, more than Aids, malaria and measles combined. Henceforth it is important to tackle these world challenges by supplying adequate octreotide drugs for the diseased. The use of octreotide in radiolabelling will substantially increase the demand for Octreotide.

The increasing popularity of generic drugs might affect the consumption of branded drugs. The availability of generic drugs is expected to grow because of cost factor and hence will affect the overall Pharmaceutical industry if not restructured according to the market and consumer needs. The important restraining factor for Octreotide Market is the lack research of Octreotide for the treatment of children, pregnant and lactating women. The use of Octreotide is based on risk factor analysis hence might affect the consumption of Octreotide.

Octreotide Market: Segmentation

On the basis of Type, global Octreotide Market is segmented into:

octreotide acetate

octreotide

octreotide chloride

octreotide hydrochloride

indium In-111; octreotide

On the basis of End use, global Octreotide Market is segmented into:

Pharmaceutical

Clinical Research

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-1266

Octreotide Market: Key market Players

Some of the Octreotide producers are Novartis pharmaceuticals corp., App pharmaceuticals llc, Bedford laboratories div ben venue laboratories Inc., Sun pharmaceutical industries ltd., Sinopharm A-THINK Pharmaceutical Co., Ltd., Teva parenteral medicines Inc., Neiss Labs Pvt. Ltd., Samarth Pharma Pvt. Ltd. J.B. Chemicals and Pharmaceuticals Ltd and others

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/

This release was published on openPR.